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COVID-19 pneumonia in children presents with very mild symptoms through an entity of multisystem inflammatory
syndrome and can result in a life-threatening hyperinflammatory condition, with involvement of at least four organ systems
and a marked inflammatory state. We present an 18-year-old high school student who presented with a sore throat, macular
rash, abdominal pain, diarrhea, fevers, and joint pains. He presented with acute kidney injury and confusion with multiple tests
and was eventually diagnosed with multisystem inflammatory syndrome in children (MIS-C).

1. Case Presentation
An 18-year-old African male high school student with no
prior comorbid conditions presented with a 2-day history of
tonsillitis and was noted to have a macular rash that started
on his chest and extended to his arm. He had received
symptomatic treatment by a school clinician with oral
chlorohexidine and lozenges. Three days into the initial
symptom, he developed abdominal cramping and multiple
episodes of non-bloody diarrhea, watery in nature, without
nausea nor vomiting. He also had fevers and joint pains
(both wrist, elbows, and knees). He was taken to a nearby
health facility, where he was noted to have a high temperature and tachycardia. Within 24 hours in this facility, he
developed confusion and was reported to have increasing
creatinine, which rose from 200 μmol/L to 400 μmol/L.
Treatment received included ceftriaxone 2 grams once a day
for three days, paracetamol 1 g three times a day, loperamide
2 mg with every episode of diarrhea, and one dose of IV
methylprednisolone 1 g. Given his deterioration, he was
transferred to our facility for further evaluation and
treatment.
On arrival at this hospital, he was tachycardic at 130
beats per minute, tachypneic with a respiratory rate of 50

breaths per minute, febrile at 40 degrees Celsius, hypotensive
at 70/40 mmHg, and desaturating to 86% on room air. His
GCS was 14/15; respiratory exam revealed bilaterally coarse
crepitations throughout the lung fields with an audible S3
gallop rhythm on cardiovascular examination. Per abdomen
was distended, tense with hypoactive bowel sounds. The
musculoskeletal examination was unremarkable. He underwent acute management with fluid resuscitation, an
urgent central line was placed, and he was initiated on
inotropic support at 0.4 mcg per kilogram per minute.
The initial laboratory findings included a full hemogram
which depicted an elevated white cell count of 27.12 × 109/L,
hemoglobin of 10.9 g/dl (normocytic normochromic), and
platelets of 281 × 109/L. Inflammatory markers were elevated
with a procalcitonin of 71.58 ng/ml and C-reactive protein of
287 mg/L. The kidney fuctions were deranged with a creatinine of 494mmol/L, urea 26.70 mmlols/L, sodium 128
mmol/L, potassium 4.87mmol/L, and bicarbonate 15.5
mmol/L (blood gas analysis supoorted a metobaolic acisosis
with a pH7.33, PCO2 23 PO2 122 and HCO3- 19.8). His liver
function test represented ischemic hepatitis with an elevated
AST of 1461 units/L ALT 812 units/L normal bilirubin
(hepatitis screens A, B, and C were negative, including an
HIV test). Urine analysis showed proteinuria with protein
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Figure 1: Computed tomography (CT) of the abdomen showing
multiple hypodense wedge-shaped parenchymal defects involving
the cortex and medulla consistent with renal infarcts (black arrow).

Figure 2: Computed tomography (CT) of the abdomen showing
hypodense pyramidal wedge-shaped defect consistent with splenic
infarcts (black arrow).

three-plus and blood four plus (with no red blood cells) and
a urine albumin creatine ratio conﬁrming proteinuria of
52.28 mg/mmol. The cardiac markers were elevated with a
troponin of 17,137 ng/ml with an elevated creatine kinase
of more than 7800 units/L. At this point, a diagnosis of
rheumatic heart disease and rheumatic fever was entertained; an ASOT titer was obtained, being negative.
His radiological investigation included a chest X-ray that
showed a feature of pulmonary edema and cardiomegaly; a
2D echo showed dilated cardiomyopathy with a low ejection
fraction of 30 to 35% and normal valves. A CTscan abdomen
showed distended bowel with splenic and renal infarcts as
highlighted in Figures 1 and 2, and an HRCT redemonstrated the cardiomegaly and bi-basal lung atelectasis.
Multiple diﬀerential diagnoses were entertained at this
point, such as vasculitis (antiphospholipid antibody syndrome, medium-sized vasculitis) and multisystemic inﬂammatory syndrome, which has been superimposed by
septic shock. Within a few hours, the patient deteriorated,
requiring intubation, and his norepinephrine requirements
had increased to 0.7 mcg per kilogram per minute. He had
been initiated on meropenem one gram three times a day
and was started on urgent dialysis to help with the pulmonary edema, and supportive management was commenced for the fevers (given liver dysfunction, paracetamol
was avoided, and other measures were integrated, which
included cooling and icepacks). Because of the above
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diﬀerential diagnosis, an autoimmune panel was sent.
Complement 3 and Complement 4 (C3 and C4) were low at
0.51 g/L and 0.04 g/L, respectively. The patient was initiated
on a low-dose steroid pulse at 250 mg once a day and, due to
the high risk of immunosuppression secondary to the steroids, was given broader cover with vancomycin 500 mg
twice a day (renally adjusted doses); the rest of the autoimmune panel results are as follows: positive beta2-glycoprotein IgA antiphospholipid antibody and negative ANA,
antiDS DNA, ENA, pANCA, and cANCA. COVID-19 PCR
from tracheal aspirate and nasal swab was negative. However, to our surprise, the COVID-19 antibody test was
positive, giving us strong evidence that our patient was
suﬀering from the multisystemic inﬂammatory syndrome.
By this point, all cultures, including blood and urine, had no
growth.
With the ﬁrst pulse of steroids, the patient showed
marked improvement with a decreasing pressor requirement
from 0.7 mcgs of norepinephrine to 0.16 mcgs. Currently,
the patient is doing well and has been successfully extubated,
oﬀ inotropic support, with good urine output. He has remarkably overcome an acute process with four days of
treatment with antibiotics and steroids and will continue on
a tapering dose of steroids. He was successfully discharged
from the hospital with some mild left leg weakness. As
demonstrated by the MRI in Figures 3 and 4, the brain had
developed small lacunar infarcts with residual neurological
deﬁcits.

2. Discussion
Multisystemic inﬂammatory syndrome in children (MIS-C)
is where you have multiple organ inﬂammation, including
the heart, lungs, kidneys, brain, skin, eyes, and gastrointestinal tract [1]. COVID-19 pneumonia in children
presents very mild symptoms and can often be asymptomatic. There is a speciﬁc criterion that should be met for
the diagnosis of MISC. As per the European and US center
of disease prevention and control the diagnostic criteria is
as follows: <21 years of age, fever for more than one day,
laboratory evidence of inﬂammation, and more than two
organ failure with a positive SARS-COVID 19 PCR or
positive antigen test [2]. As seen in our case, the criteria
were met given that the patient was 18 years old and had
increased inﬂammatory markers evidenced by increased
CRP and ferritin levels. The patient also had multiple organ
failure including a positive antigen test, including the heart,
lungs, kidneys, and brain.
The pathogenesis of COVID-19 pneumonia in children
is similar to that of adults, where viral entry is via angiotensin-converting enzyme receptor 2, the diﬀerence being
that fewer receptors in children give milder symptoms. In
MIS-C, once the viral entry has been established, the early
infection activates the macrophages after the T-helper cells
causing cytokine release [3]. One after that develops a hyperimmune state by activating the B-cells causing the
production of autoantibodies. The hyperimmune state leads
to autoantibodies attacking the endothelial cell and gastrointestinal cells; myocardial damage’s exact mechanism is
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(a)
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Figure 3: ADC mapping with an area of low signal intensity (left image orange arrow). Diﬀusion-weighted image showing high signal
intensity (right image orange arrow).

(a)

(b)

Figure 4: Flair MR image showing high signal intensity (left image orange arrow) and corresponding T2-weighted image showing an area of
high signal intensity (right image orange arrow).

unknown, but one can present with myocarditis or acute
ischemic events [3].
The clinical presentation of MIS-C is a multisystemic
disease, one of the most common manifestations is fevers
occurring in 97–100% of patients, and dermatological
manifestation includes rash and conjunctivitis (30–94%) [4].
Gastrointestinal (GI) manifestation are the most common
presenting complaints which include abdominal pain,
vomiting, and diarrhea [4]. Cardiac involvement includes
features of myocarditis and ischemic events; around
31–100% of the patients may have left ventricular diastolic
function evidenced by an echocardiogram [4]. Thrombotic
complications like splenic infarction and cerebral strokes are
also common manifestations [5]. On the other hand, renal
infarctions are rare, and only a few cases reported in patients
with COVID-19 pneumonia have developed renal infarctions [6–8]. Based on this evidence, one can see that the
above patient presented with almost all the clinical signs
making the diagnosis even stronger.
Acute kidney injury is prevalent amongst the SARSCOVID-19 patients. AKI and renal parenchymal disease
may be caused by the ACE-2 receptors on the kidney parenchyma, causing microvascular injury triggered by the
cytokine storm [9, 10]. As noted in outpatient, there was
proteinuria, which has been reported in COVID-19 pneumonia patients. The theory is that viral replication occurs in
the podocytes causing damage that can ensue in proteinuria
[10]. Renal infarction resulting in AKI is rare; studies have

shown renal infarction resulting in AKI but none requiring
hemodialysis [7]. This case stands out as it is one of the only
cases of renal infarction requiring renal replacement therapy. Most cases of renal infarction lead to AKI with no
additional intervention required.
There is a unique coloration between SARS-COVID-19
pneumonia and antiphospholipid antibody syndrome;
there can be an elevated anticardiolipin IgA antibody or an
anti-B2-glycoprotein I IgA and IgG antibodies (as seen in
our patient); this manifestation can lead to cerebral vascular infarctions, although studies do not support this
hypothesis as in antiphospholipid syndrome it is the IgM
and IgG titers that collate to thrombotic events [11].
Further studies need to be conducted to prove the
thrombotic sequela amongst those with increased IgA titer,
as clearly evidenced not only in our patient but in other
case series conducted by Zhang et al., where all three
patients had thrombotic events (multiple cerebral infarctions) and positive anticardiolipin IgA, anti-β2-glycoprotein I IgA, and IgG [12].
MIS-C and COVID-19 pneumonia is a pediatric syndrome characterized by increased inﬂammatory markers,
fever, and multiorgan failure. There is a signiﬁcant increase
in the risk of morbidity and mortality, but some cases have a
reasonable response rate, as seen in our patient. The unique
events of positive IgA antiphospholipid antibodies and
thrombotic events as seen in our patient may need further
studies to prove any correlations.
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3. Conclusion
COVID-19 pneumonia can lead to MIS-C resulting in
multiple organ inﬂammation. Patients with MIS-C are more
prone to thrombotic events and multiple organ failures.
Therapies with steroids and intravenous immunoglobulins
have been shown to improve outcomes signiﬁcantly. AKI
caused by renal infarction is rare; this may be the only case
resulting in renal infarction requiring renal replacement
therapy.
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